Location History:
- San Francisco, CA (US) (1982 - 1998)
- Heidelberg, DE (1993 - 2001)
Company Filing History:
15 out of 3,223 
4 out of 15,488 
1 out of 832,891 Years Active: 1982-2001
Title: The Innovations of Peter H. Seeburg: A Pioneer in Endocrine Research
Introduction
Peter H. Seeburg, based in San Francisco, CA, is renowned for his significant contributions to the field of endocrinology and molecular biology. With a remarkable portfolio of 20 patents, his work has paved the way for advancements in hormone research and its therapeutic applications.
Latest Patents
Among his latest innovations, Seeburg has developed a patent related to the luteinizing hormone/choriogonadotropin (LH/CG) receptor. This invention focuses on the purification and cloning of receptors for hormones such as luteinizing hormone, choriogonadotropin, follicle stimulating hormone, and thyroid stimulating hormone. The implications of this work are profound, as it offers new avenues for diagnosis and therapy in various human conditions. Additionally, Seeburg isolated nucleic acids encoding both the mature beta chain of inhibin and the prepro inhibin alpha and beta chains. By ligating this DNA into expression vectors, he has advanced methods for transforming host cells to prepare inhibin or activin, which are crucial in manipulating fertility in animals.
Career Highlights
Peter H. Seeburg's career includes significant roles at influential institutions. He has contributed to the advancements in biomedical research while working at Genentech, Inc. and the University of California. His experience in these esteemed organizations has strengthened his expertise and allowed him to focus on impactful research.
Collaborations
Throughout his career, Seeburg has collaborated with notable colleagues, including Anthony J. Mason and Howard M. Goodman. These partnerships have likely enhanced the scope and depth of his research, facilitating the development of innovative strategies in the field of hormone biology.
Conclusion
Peter H. Seeburg continues to leave a lasting impact on the fields of endocrinology and biotechnology. His numerous patents and collaborations illustrate his dedication to advancing scientific knowledge and developing new therapeutic options in medicine. As he moves forward, his innovations are sure to contribute to further breakthroughs in hormone-related research and its applications.